Skip to main content
SAM CHUN DANG PHARM CO. LTD logo

SAM CHUN DANG PHARM CO. LTD — Investor Relations & Filings

Ticker · 000250 ISIN · KR7000250001 KO Manufacturing
Open in API
Filings indexed 224 across all filing types
Latest filing 2020-07-22 Report Publication Anno…
Country KR South Korea
Listing KO 000250

About SAM CHUN DANG PHARM CO. LTD

http://www.scd.co.kr/english/scd/index.…

SAM CHUN DANG PHARM CO. LTD. is a pharmaceutical company focused on the development, manufacturing, and sale of medications. The company specializes in ophthalmic products, establishing itself as a significant player in the generic eye care market. Its portfolio also extends to other therapeutic areas, including antibiotics and medications for the circulatory system. The company produces a range of ethical (prescription) and over-the-counter (OTC) drugs in both sterile and non-sterile forms. Manufacturing operations adhere to international quality standards, holding both US and EU Good Manufacturing Practice (GMP) certifications.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an Investor Relations (IR) event (Non-deal Roadshow). It provides the date, location, purpose, and contact information for the meeting. Since it is an announcement of an upcoming event and mentions that materials will be distributed or made available later, it falls under the category of a regulatory announcement regarding corporate activities.
2020-07-22 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Samchundang Pharm regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the issuance of new shares resulting from the conversion of debt into equity. According to the provided categories, 'Share Issue/Capital Change' (SHA) is the most appropriate classification for announcements regarding new share issues or capital structure changes resulting from such conversions.
2020-07-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This type of filing is a mandatory disclosure for major shareholders or executives regarding changes in their shareholdings, which falls under the category of 'Major Shareholding Notification' (MRQ) in the provided classification schema.
2020-07-16 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Samchundang Pharm Co., Ltd. for the period ending March 31, 2020. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-14 Korean
투자판단관련주요경영사항(아일리아 바이오시밀러 SCD411 제제 미국 FDA 임상 3상 시험계획 승인)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Samchundang Pharm regarding the approval of a Phase 3 clinical trial for their biosimilar product by the US FDA. It is a formal disclosure of a material business event (major management matter) required by regulatory authorities. Since it does not fit into specific categories like financial reports, dividends, or share transactions, and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2020-05-13 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from Samchundang Pharm regarding the acquisition of a patent for an ophthalmic pharmaceutical composition. It is filed as a 'voluntary disclosure' (자율공시) under the category of 'Other Management Matters' (기타 경영사항). Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory announcement of a corporate event, it falls under the general regulatory filing category.
2020-04-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.